Equity Profile

WAY

Waystar Holding Corp.

Health CareHealth Care Technology$4.8B

Jul29Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Waystar Holding Corp. is a health care technology company that provides solutions to streamline the revenue cycle for healthcare providers....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing its costs and generating profit.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and attract new clients, which is vital for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

WAY Q2-2026 Earnings Preview

Context

Company Snapshot

Waystar Holding Corp. is a health care technology company that provides solutions to streamline the revenue cycle for healthcare providers. As the healthcare sector increasingly adopts technology to improve efficiency and patient care, Waystar plays a crucial role in helping organizations manage their financial processes effectively.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+72.77%

Avg Stock Reaction

+1.09%

Last Quarter Recap

In Q1-2026, Waystar reported an EPS of $0.42, exceeding expectations by 19.32%. The stock saw a slight increase of 0.16% the following day, indicating a positive market reaction.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are looking for Waystar to continue its trend of beating EPS estimates, as it has done consistently in the past. The market is particularly focused on how the company is navigating the competitive landscape in health care technology.

Bull Case

If Waystar can deliver strong EPS and demonstrate solid revenue growth, it could reinforce investor confidence and lead to a significant stock price increase.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price, especially given the high implied volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's strong track record of beating EPS estimates, this number will be crucial for investor sentiment.

How is Waystar addressing competition in the health care technology space?

Understanding the competitive landscape will help investors gauge the company's future growth potential and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Waystar's ability to leverage its technology to capture more market share, especially in a rapidly evolving health care landscape.

Supporting Evidence

Waystar has consistently beaten EPS estimates, indicating strong operational execution.

The options market is pricing a significant move, suggesting that investors are anticipating a notable shift in sentiment.

Historical trends show that the stock has reacted positively to earnings beats, reinforcing the potential for upside.

Key Risk

If Waystar manages to exceed EPS expectations significantly, it could challenge the current cautious sentiment in the market.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for continued growth against the challenges posed by competition and market conditions.

Bull Confirmed If

An EPS of $0.45 or higher would confirm the bull case and suggest strong operational performance.

Bear Confirmed If

An EPS below $0.35 would raise concerns about the company's profitability and growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±24.74%

Historical Avg

±1.6%

Pricing rich

The options market is pricing in a significant potential move in either direction, indicating uncertainty about the upcoming earnings report.

Options are pricing ±24.7% while WAY has averaged ±1.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

68.4%

Calls (2K)P/C Ratio: 0.39Puts (700)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Waystar beats expectations, history suggests the stock could rise by around 1.09% on the following day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the market may react cautiously, leading to minimal movement as investors await further guidance.

Miss

A miss could result in a significant drop, with historical data indicating a potential decline of around 1.61%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new client acquisitions or partnerships in the health care sector.
2Details on cost management strategies and their impact on profitability.
3Insights into how Waystar plans to differentiate itself from competitors.
4Management's outlook on future revenue growth and market conditions.
5Any commentary on regulatory changes affecting the health care technology industry.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

PreviewView

Jul27

ARLPBMO

Company Snapshot

Waystar Holding Corp. is a health care technology company that provides solutions to streamline the revenue cycle for healthcare providers....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing its costs and generating profit.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and attract new clients, which is vital for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

WAY Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+72.77%

Avg Stock Reaction

+1.09%

Last Quarter Recap

In Q1-2026, Waystar reported an EPS of $0.42, exceeding expectations by 19.32%. The stock saw a slight increase of 0.16% the following day, indicating a positive market reaction.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Waystar can deliver strong EPS and demonstrate solid revenue growth, it could reinforce investor confidence and lead to a significant stock price increase.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price, especially given the high implied volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's strong track record of beating EPS estimates, this number will be crucial for investor sentiment.

How is Waystar addressing competition in the health care technology space?

Understanding the competitive landscape will help investors gauge the company's future growth potential and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Waystar's ability to leverage its technology to capture more market share, especially in a rapidly evolving health care landscape.

Supporting Evidence

Waystar has consistently beaten EPS estimates, indicating strong operational execution.

The options market is pricing a significant move, suggesting that investors are anticipating a notable shift in sentiment.

Historical trends show that the stock has reacted positively to earnings beats, reinforcing the potential for upside.

Key Risk

If Waystar manages to exceed EPS expectations significantly, it could challenge the current cautious sentiment in the market.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for continued growth against the challenges posed by competition and market conditions.

Bull Confirmed If

An EPS of $0.45 or higher would confirm the bull case and suggest strong operational performance.

Bear Confirmed If

An EPS below $0.35 would raise concerns about the company's profitability and growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±24.74%

Historical Avg

±1.6%

Pricing rich

The options market is pricing in a significant potential move in either direction, indicating uncertainty about the upcoming earnings report.

Options are pricing ±24.7% while WAY has averaged ±1.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

68.4%

Calls (2K)P/C Ratio: 0.39Puts (700)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Waystar beats expectations, history suggests the stock could rise by around 1.09% on the following day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the market may react cautiously, leading to minimal movement as investors await further guidance.

Miss

A miss could result in a significant drop, with historical data indicating a potential decline of around 1.61%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new client acquisitions or partnerships in the health care sector.
2Details on cost management strategies and their impact on profitability.
3Insights into how Waystar plans to differentiate itself from competitors.
4Management's outlook on future revenue growth and market conditions.
5Any commentary on regulatory changes affecting the health care technology industry.